Vanguard Group’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
Other funds holding CVAC
OBAM
CL
Vanguard Group's CVAC Position: Q4 2025 in Review
Vanguard Group sold out of CureVac (CVAC) in Q4 2025, closing a stake of 96,051 shares — an estimated $514K sold.
Vanguard Group first reported a position in CVAC in Q1 2021 and held it in 19 quarters. The position peaked at $6.05M in Q2 2021. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.
- Vanguard Group reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
- Vanguard Group sold 96,051 CureVac shares in Q4 2025, an estimated $514K.
- Vanguard Group first reported a position in CureVac in Q1 2021 and held it in 19 quarters.
- Vanguard Group's CureVac position peaked at $6.05M in Q2 2021.
- 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.